InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: dia76ca post# 13499

Saturday, 04/16/2022 9:15:06 PM

Saturday, April 16, 2022 9:15:06 PM

Post# of 14953
This small cell lung cancer trial is one of half a dozen trials Sorrento partnered with Lee's Pharma.
Lee’s Pharm is a public biopharma company with over 20 years of operation in China and currently markets 14 products in the PRC.

Sorrento has licensed exclusive rights to Lee’s Pharm to develop and commercialize the fully human anti-PD-L1 mAb STI-A1014 for the greater Chinese market.

Sorrento has an other PD-L1 drug partnered with a Korean partner. It is in trials in Korea and the US.

"The refusal of the real is the number one dogma of our time" Rene Girard